List of Studies ( Metabolite:Atenolol)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004153 | AN006894 | Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model | Feces | Rat | Shanghai Jiao Tong University | LC-MS | |
| ST004105 | AN006807 | Untargeted LC-MS/MS- Based Metabolomics Profiling of Colorectal Cancer Cell Lines Reveals Potential Hypoxia-Associated Biomarkers | Cultured cells | Human | Cancer | Sharjah Institute for Medical Research | LC-MS |
| ST004093 | AN006783 | Autoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation | T-cells | Mouse | Autoimmune disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003930 | AN006453 | Acylated putrescine therapeutic discovery for Inflammatory Bowel Diseases: HILIC-pos profiling of mouse fecal samples | Feces | Mouse | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003880 | AN006373 | Untargeted metabolome analysis of control and disease intervertebral disc tissue | Tissue | Human | Bone disease | Ganga Orthopaedic Research and Education Foundation | LC-MS |
| ST003788 | AN006443 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Meningitis | Broad Institute of MIT and Harvard | LC-MS |
| ST003788 | AN006443 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Tuberculosis | Broad Institute of MIT and Harvard | LC-MS |
| ST003439 | AN005670 | Metabolomics of human serum to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part1 human metabolites) | Blood | Human | Sepsis | Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute | LC-MS |
| ST003327 | AN005451 | Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial Metabolomics | Blood | Human | Trauma | University of Colorado Anschutz Medical Campus | LC-MS |
| ST003172 | AN005206 | Untargeted Metabolomic Profile Of Chili Pepper (Capsicum Chinensed) Developmental Cycle | Capsicum Chinense | Habanero pepper | University of Alberta | LC-MS | |
| ST003085 | AN005044 | Metabolome changes in embryonic CSF (Part 7) | Cerebrospinal fluid | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003039 | AN004986 | A Non-Targeted Metabolomics Comparative Study on Plasma of Pfizer and Sinopharm COVID- 19 Vaccinated individuals, Assessed by (TIMS-QTOF) Mass Spectrometry. | Blood | Human | COVID-19 | Sharjah Institute for Medical Research | LC-MS |
| ST003029 | AN004966 | Estrogen-mediated inhibition of purine metabolism and cell cycle arrest as a novel therapeutic approach in colorectal cancer cells | Colorectal Cancer Cells | Human | Cancer | Sharjah Institute for Medical Research | LC-MS |
| ST002977 | AN004887 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | LC-MS | |
| ST002977 | AN004889 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | LC-MS | |
| ST002976 | AN004886 | Metabolomics Insights into Doxorubicin and 5-Fluorouracil Combination Therapy in Triple-Negative Breast Cancer: A Xenograft Model Study (Part 2) | Blood | Mouse | Cancer | Sharjah Institute for Medical Research | LC-MS |
| ST002903 | AN004762 | Identification and targeting of microbial putrescine acetylation in bloodstream infections | Blood | Human | Septic shock | Broad Institute of MIT and Harvard | LC-MS |
| ST002820 | AN004594 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | Other | |
| ST002819 | AN004590 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | Other | |
| ST002818 | AN004586 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | Other | |
| ST002576 | AN005612 | Role of environmental toxicants in obesity-related cardiovascular disease: Plasma untargeted LC-HRMS analysis (part 1 of 3) | Blood | Human | Heart disease | Boston University | LC-MS |
| ST002536 | AN004171 | Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma | Thyroid | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST002498 | AN004654 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | LC-MS |
| ST002473 | AN004039 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Veillonella parvula media profiling of IBD drug metabolites | Culture media | Veillonella parvula | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002472 | AN004037 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Veillonella parvula cell and media profiling | Bacterial cells | Veillonella parvula | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002471 | AN004033 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Feces | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002273 | AN003715 | Multi-Omics analysis revealed a significant alteration of critical metabolic pathways due to sorafenib-resistance in Hep3B cell lines | Cultured cells | Human | Cancer | Sharjah Institute for Medical Research | LC-MS |
| ST002247 | AN003670 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002246 | AN003666 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002089 | AN003410 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002088 | AN003406 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002028 | AN003298 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) | Feces | Human | University of California, Davis | LC-MS | |
| ST002027 | AN003297 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) | Blood | Human | University of California, Davis | LC-MS | |
| ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | LC-MS |
| ST002003 | AN003266 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 4) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001990 | AN003243 | METABOLOMICS OF THE INTERACTION BETWEEN A CONSORTIUM OF ENTOMOPATHOGENIC FUNGI AND THEIR TARGET INSECT: MECHANISMS OF ATTACK AND SURVIVAL. | Insect tissue | European pepper moth | Universidade Federal do Paraná | API-MS | |
| ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001876 | AN003038 | Metabolomics analysis of multiple samples on Agilent 6546-Part 2 | Feces | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001876 | AN003038 | Metabolomics analysis of multiple samples on Agilent 6546-Part 2 | Liver | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Feces | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Liver | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Blood | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Hep G2 cells | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Urine | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Blood | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Hep G2 cells | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Urine | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001753 | AN002856 | Modifying Chromatography Conditions for Improved Unknown Feature Identification in Untargeted Metabolomics | Blood | Human | University of Michigan | LC-MS | |
| ST001749 | AN002848 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin-Madison | LC-MS |
| ST001639 | AN002681 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST001519 | AN002525 | Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001237 | AN002055 | Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part III | Blood | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST001236 | AN002054 | Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part II | Blood | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST001192 | AN001984 | A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001000 | AN001878 | Gut microbiome structure and metabolic activity in inflammatory bowel disease | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST000975 | AN001596 | GC6-74 metabolomics of TB vs healthy (Part 2: Serum) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000923 | AN001513 | Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease | Feces | Human | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
